While there have been no recent clinical trials of saporin conjugates for cancer treatment, saporin conjugated to substance P for pain management was found to safe in a Phase I clinical trial (NCT02036281) and was successfully used for pain management in dogs with bone cancer40. The gene discussed is TAC1; the disease is cancer.